<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="molecules-24-01364-t034" orientation="portrait" position="float" class="table-wrap">
 <object-id pub-id-type="pii" class="object-id">molecules-24-01364-t034_Table 34</object-id>
 <label class="label">Table 34</label>
 <caption class="caption">
  <p class="p">Clinical trials on patients with generalized anxiety disorder.</p>
 </caption>
 <table frame="hsides" rules="groups" class="table">
  <thead class="thead">
   <tr class="tr">
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Design</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Treatment</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Patients (n)</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Key Effects</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">References</th>
   </tr>
  </thead>
  <tbody class="tbody">
   <tr class="tr">
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <bold class="bold">Clinical trial</bold>
     <break class="break"/>randomized
     <break class="break"/>double-blind
     <break class="break"/>placebo-controlled
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract
     <break class="break"/>(3 X 100 mg)/day
     <break class="break"/>
     <bold class="bold">Duration:</bold> 4 Weeks
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <italic class="italic">n</italic> = 58
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-Hamilton-Anxiety-Scale (HAMA) Score significantly reduced in drug receiving group compared to placebo group.
     <break class="break"/>-No adverse effects.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B367-molecules-24-01364" ref-type="bibr" class="xref">367</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <bold class="bold">Clinical trial</bold>
     <break class="break"/>randomized
     <break class="break"/>double-blind
     <break class="break"/>placebo-controlled
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract
     <break class="break"/>(3 X 110mg)/day
     <break class="break"/>
     <bold class="bold">Duration:</bold> 25 Weeks
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <italic class="italic">n</italic> = 101
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-Significant superiority of kava extract in Hamilton-Anxiety-Scale (HAMA) Score over the placebo starting from week 8.
     <break class="break"/>-Rare and evenly distributed adverse effects.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B368-molecules-24-01364" ref-type="bibr" class="xref">368</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <bold class="bold">Clinical trial</bold>
     <break class="break"/>randomized
     <break class="break"/>double-blind
     <break class="break"/>placebo-controlled
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract
     <break class="break"/>(280 mg)/day
     <break class="break"/>
     <bold class="bold">Duration:</bold> 4 Weeks
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <italic class="italic">n</italic> = 13
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-Significantly improved baroreflex control of heart rare following treatment with placebo.
     <break class="break"/>-No effect on respiratory sinus arrhythmia.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B407-molecules-24-01364" ref-type="bibr" class="xref">407</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <bold class="bold">Clinical trial</bold>
     <break class="break"/>randomized
     <break class="break"/>open study
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract
     <break class="break"/>(100 and 200 mg)/day
     <break class="break"/>
     <bold class="bold">Duration:</bold> 3 Months
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <italic class="italic">n</italic> = 80
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-In kava treatment groups anxiety climacteric score declined at 1.and 3. Months.
     <break class="break"/>-Depression reduced at month 3.
     <break class="break"/>-In control group no significant result.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B413-molecules-24-01364" ref-type="bibr" class="xref">413</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <bold class="bold">Clinical trial</bold>
     <break class="break"/>double-blind
     <break class="break"/>crossover trial
     <break class="break"/>placebo-controlled
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract
     <break class="break"/>5 tablets/day
     <break class="break"/>Containing 3.2 g extract (delivering 50 mg kavalactones)
     <break class="break"/>
     <bold class="bold">Duration:</bold> 1 month
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <italic class="italic">n</italic> = 60
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-Kava resulted in 11.4 points reduction on HAMA Score over placebo.
     <break class="break"/>-Antidepressant effect.
     <break class="break"/>-No serious adverse effect.
     <break class="break"/>-No clinical hepatotoxicity.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B416-molecules-24-01364" ref-type="bibr" class="xref">416</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <bold class="bold">Clinical trial</bold>
     <break class="break"/>randomized
     <break class="break"/>double-blind 
     <break class="break"/>placebo-controlled
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract1 or 2 tablet/day
     <break class="break"/>(120 or 240 mg) kavalactone
     <break class="break"/>
     <bold class="bold">Duration:</bold> 6 Weeks
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <italic class="italic">n</italic> = 75
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-Significant increase in femaleâ€™s sexual drive in Kava group compared to placebo (assessed by ASEX).
     <break class="break"/>-Significant reduction of anxiety in Kava group compared to placebo (assessed by HAMA).
     <break class="break"/>-No significant differences across groups for liver function test.
     <break class="break"/>-No differences in withdraw or addiction.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B417-molecules-24-01364" ref-type="bibr" class="xref">417</xref>,
     <xref rid="B418-molecules-24-01364" ref-type="bibr" class="xref">418</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
